| Systematic (IUPAC) name | |
|---|---|
| 3-[5-(4-Chlorophenyl)-1-(4-methoxyphenyl)pyrazol-3-yl]-N-hydroxy-N-methylpropanamide | |
| Clinical data | |
| AHFS/Drugs.com | International Drug Names |
| Pregnancy cat. | ? |
| Legal status | Veterinary use only |
| Routes | Oral |
| Identifiers | |
| ATCvet code | QM01AE92 |
| PubChem | CID 59757 |
| UNII | TZ4OX61974 |
| KEGG | D06075 |
| Chemical data | |
| Formula | C20H20ClN3O3 |
| Mol. mass | 385.844 g/mol |
| (what is this?) (verify) |
|
Tepoxalin is a nonsteroidal anti-inflammatory drug approved for veterinary use (in dogs) in the United States and the European Union. It is primarily used to reduce inflammation and relief of pain caused by musculoskeletal disorders such as hip dysplasia and arthritis.
It is generally marketed under the brand name Zubrin.